Concepedia

H Niitani

HN

22

Publications

1.6K

Citations

16

H-Index

1978

Active since

Affiliations

Nippon Medical School(Current)

Kinki Central Hospital

Japan Clinical Cancer Research Organization

Chiba University

Osaka Prefectural Medical Center

H Niitani is an author at Nippon Medical School specializing in medicine, oncology, and lung cancer.

Top concepts

Publications per year

1978–2002

22

Publications

22

A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer.

M. Fukuoka, H Niitani, Atsushi Suzuki et al. · Journal of Clinical Oncology · 1992 · 434 citations

Phase I Study of Weekly Intravenous Infusions of CPT-11, a New Derivative of Camptothecin, in the Treatment of Advanced Non-Small-Cell Lung Cancer

S. Negoro, M. Fukuoka, N Masuda et al. · JNCI Journal of the National Cancer Institute · 1991 · 274 citations

[Phase II study].

H Niitani · PubMed · 1995 · 167 citations

, , +11

Phase II trial of docetaxel in previously untreated advanced non-small-cell lung cancer: a Japanese cooperative study.

Hideo Kunitoh, Kyohei Watanabe, T Onoshi et al. · Journal of Clinical Oncology · 1996 · 136 citations

Phase II Study of Vinorelbine in Heavily Previously Treated Small Cell Lung Cancer

Kiyoyuki Furuse, Kaoru Kubota, Masaaki Kawahara et al. · Oncology · 1996 · 82 citations

Rows per page

1–5 of 22